Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alfonso Ballesteros

Surgery Sun City, AZ Medical Doctor

NPI 1497957815 CMS profile 204413

14416 W Meeker Blvd Ste 100, Sun City, AZ 85375

Open in the dashboard

General payments

$35,486

88 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alfonso Ballesteros of Sun City, AZ is reported in the CMS Open Payments database as having received $35,486 across 88 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,443 20
2024 General $3,573 13
2023 General $5,691 17
2022 General $10,950 15
2021 General $9,268 12
2020 General $113 4
2019 General $449 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alfonso Ballesteros
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Alfonso Ballesteros were reported at $5,443. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Alfonso Ballesteros Surgery median Middle half National median
2019 $449 $253 $82–$1,521 $163
2020 $113 $131 $40–$706 $114
2021 $9,268 $168 $50–$904 $132
2022 $10,950 $224 $76–$1,218 $149
2023 $5,691 $253 $82–$1,255 $160
2024 $3,573 $279 $90–$1,381 $164
2025 $5,443 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $33,249 49 payments
  2. Davol Inc. $1,841 24 payments
  3. Ethicon US, LLC $237 8 payments
  4. Solventum Corporation $49 2 payments
  5. Boston Scientific Corporation $31 1 payment
  6. CONMED Corporation $26 1 payment
  7. Becton, Dickinson and Company $22 1 payment
  8. KCI USA, Inc $17 1 payment
  9. Smith+Nephew, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $28,548 15 payments
  2. Food and Beverage $4,248 62 payments
  3. Travel and Lodging $2,690 11 payments
Products named General payments · program years 2019–2025
  1. DAVINCI XI $19,500 10 payments
  2. Da Vinci Surgical System Surgery $9,000 3 payments
  3. Da Vinci Surgical System Surgery $4,749 36 payments
  4. Phasix Mesh Surgery $911 13 payments
  5. Phasix Mesh BD Interventional Surgery $829 8 payments
  6. EVARREST $85 1 payment
  7. ULTRA VAC $85 1 payment
  8. V.A.C.INSTILL $65 3 payments
  9. Echelon Flex $58 1 payment
  10. PHASIX $56 2 payments
  11. Other $452 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

337

Median for General Surgery: 59

Drug cost

$2,053

Median for General Surgery: $393

Branded share of claims

42.7%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Naloxone Hcl Generic 12 $791
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 144 $568
Ondansetron Hcl Generic 145 $437
Gabapentin Generic 13 $185
Metronidazole Generic 11 $57
Oxycodone Hcl Generic 12 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$127,980

Medicare's payments for the services billed

Medicare patients

316

Average age 76

Services billed

655

139 women, 177 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Chronic kidney disease 40%
Ischemic heart disease 35%
Diabetes 30%
Atrial fibrillation 27%
Depression 24%
Cancer 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record